Implementation of Practice Standards for ECG Monitoring (PULSE)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01269736 |
Recruitment Status :
Completed
First Posted : January 4, 2011
Results First Posted : August 31, 2017
Last Update Posted : August 31, 2017
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Cardiovascular Disease | Behavioral: Education | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 92057 participants |
Allocation: | Randomized |
Intervention Model: | Crossover Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Health Services Research |
Official Title: | Implementation of Practice Standards for ECG Monitoring |
Study Start Date : | August 2008 |
Actual Primary Completion Date : | March 2014 |
Actual Study Completion Date : | March 2014 |
Arm | Intervention/treatment |
---|---|
Experimental: Education
Online ECG monitoring education program and strategies to implement and sustain change for nurses
|
Behavioral: Education
Online ECG monitoring education program and strategies to implement and sustain change for nurses |
No Intervention: Control
Usual in-service education for nurses
|
- Nurses' Knowledge and Skills Related to ECG Monitoring [ Time Frame: Baseline, 15 months, 30 months ]Participants took a 20-item online test on essentials of ECG monitoring, and arrhythmia, ischemia, and QT interval monitoring. Scores represent the percentage of correct answers. (Test scores range from 0 to 100 with higher scores representing more correct answers)
- Quality of Patient Care Related to ECG Monitoring [ Time Frame: Baseline, 15 months, 30 months ]Percentage of patients with accurate electrode placement, accurate rhythm interpretation, cardiac arrest, cardiac arrest initiated by arrhythmia, appropriate monitoring, telemetry units only, ST-segment monitoring when indicated, and QTc measurement when indicated
- Patient Outcomes [ Time Frame: Baseline, 15 months, 30 months ]Mortality, in-hospital MI, and not surviving a cardiac arrest were obtained using administrative data and laboratory data (eg, troponin, CK-MB) for all patients. Mortality was defined as death that occurred on one of the participating units. To identify the occurrence of in-hospital MI, laboratory data, timing of procedures, and location of patient at the time of the first blood draw indicating the event were used. Cardiac arrest was defined as an event initiated by an arrhythmia that required immediate intervention and was initiated on a PULSE participating unit. For each qualifying cardiac arrest, it was determined whether the patient survived the event.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | Child, Adult, Older Adult |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Nurses (and monitor technicians): All nurses (and monitor technicians) working on participating units serving patients with cardiac disease
- Patients: All patients cared for on participating units
Exclusion Criteria:
- Nurses (and monitor technicians): No nurses (or monitor technicians) will be excluded
- Patients: No patients on the participating units will be excluded, even if their primary diagnosis is not cardiac

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01269736
United States, California | |
Long Beach Memorial Medical Center | |
Long Beach, California, United States, 90806 | |
University of California, San Francisco Medical Center | |
San Francisco, California, United States, 94122 | |
United States, Connecticut | |
Yale-New Haven Hospital | |
New Haven, Connecticut, United States, 06510 | |
United States, Maine | |
Maine Medical Center | |
Portland, Maine, United States, 04102 | |
United States, Massachusetts | |
Baystate Medical Center | |
Springfield, Massachusetts, United States, 01199 | |
United States, Minnesota | |
United Hospital | |
Saint Paul, Minnesota, United States, 55102 | |
United States, New York | |
Erie County Medical Center | |
Buffalo, New York, United States, 14215 | |
United States, North Carolina | |
University of North Carolina Hospitals | |
Chapel Hill, North Carolina, United States, 27516 | |
United States, Ohio | |
Aultman Hospital | |
Canton, Ohio, United States, 44710 | |
United States, Pennsylvania | |
Hospital of the University of Pennsylvania | |
Philadelphia, Pennsylvania, United States, 19104 | |
Thomas Jefferson University Hospital | |
Philadelphia, Pennsylvania, United States, 19107 | |
United States, Texas | |
Seton Medical Center | |
Austin, Texas, United States, 78705 | |
Baylor University Medical Center | |
Dallas, Texas, United States, 75252 | |
United States, Wisconsin | |
Meriter Heart Hospital | |
Madison, Wisconsin, United States, 53715 | |
Canada, Ontario | |
University of Ottawa Heart Institute, Ottawa, Canada | |
Ottawa, Ontario, Canada, K1Y 4W7 | |
China | |
Hong Kong Sanatorium & Hospital | |
Hong Kong, China |
Principal Investigator: | Marjorie Funk, PhD, RN | Yale University School of Nursing |
Other Publications:
Responsible Party: | Yale University |
ClinicalTrials.gov Identifier: | NCT01269736 |
Other Study ID Numbers: |
0711003292 R01HL081642 ( U.S. NIH Grant/Contract ) |
First Posted: | January 4, 2011 Key Record Dates |
Results First Posted: | August 31, 2017 |
Last Update Posted: | August 31, 2017 |
Last Verified: | June 2017 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
electrocardiographic monitoring arrhythmia myocardial ischemia |
Cardiovascular Diseases |